Osciflex

company

About

Osciflex system imitates nature’s process to prevent deadly blood clots.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$0.99M
Industries
Health Care,Medical,Medical Device,Pharmaceutical
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Osciflex system imitates nature’s process to prevent deadly blood clots. Osciflex developing a more effective compression therapy device that can better prevent Venous thromboembolism (VTE) in patients and reduce the use of expensive and risky anti-coagulation pharmaceuticals.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.22M
Osciflex has raised a total of $1.22M in funding over 2 rounds. Their latest funding was raised on Dec 28, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 28, 2021 Grant $0.99M 1 National Science Foundation Detail
Jan 29, 2019 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Osciflex is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant